Bio-Techne (NASDAQ: TECH) reported quarterly earnings of $0.53 per share which missed the analyst consensus estimate of $0.54 by 1.85 percent. This is a 5.36 percent decrease over earnings of $0.56 per share from the same period last year. The company reported quarterly sales of $311.415 million which missed the analyst consensus estimate of $317.093 million by 1.79 percent. This is a 1.51 percent decrease over sales of $316.181 million the same period last year.